Loading...

Purified anti-Nuclear Pore Complex Proteins Antibody (Previously Covance catalog# MMS-120P)

Pricing & Availability
Clone
MAb414 (See other available formats)
Regulatory Status
RUO
Other Names
107 kD nucleoporin, NPC proteins, Nuclear pore complex protein Nup107, Nucleoporin 107kD, Nucleoporin Nup107, NUP 107, NUP 84, NUP107, NUP153, NUP155, NUP84, NUP98
Previously
Covance Catalog# MMS-120P
Isotype
Mouse IgG1
Ave. Rating
Submit a Review
Product Citations
publications
1_MAb414_Pure_NPCP_Antibody_111417
Immunofluorescence of HeLa with Nuclear Pore Complex Proteins Mouse primary antibody. Alexa Fluor® 594 (Red) Goat anti-Mouse IgG (Cat. No. 405326) was used as secondary antibody. Nuclei were counterstained with DAPI (Blue, Cat. No. 422801). Exposure time is 80 ms. Concentration is 1 µg/ml.
  • 1_MAb414_Pure_NPCP_Antibody_111417
    Immunofluorescence of HeLa with Nuclear Pore Complex Proteins Mouse primary antibody. Alexa Fluor® 594 (Red) Goat anti-Mouse IgG (Cat. No. 405326) was used as secondary antibody. Nuclei were counterstained with DAPI (Blue, Cat. No. 422801). Exposure time is 80 ms. Concentration is 1 µg/ml.
  • 2_MAb414_Pure_NPCP_Antibody_ICC_122117
    HeLa cells were fixed with 4% paraformaldehyde (PFA) for 15 minutes, permeabilized with 0.5% Triton X-100 for 3 minutes, and blocked with 5% FBS for 60 minutes. Then the cells were intracellularly stained with (A) mouse IgG1, κ isotype control (Negative, Cat. No. 401402) or (B-D) Nuclear Pore Complex (Clone Mab414) overnight at 4°C followed by Alexa Fluor® 647 (Red) Goat anti-Mouse IgG (Cat. No. 405322) incubation for one hour at room temperature. The image was captured with a 60X objective using KEYENCE BZ-X700 fluorescence microscope. Exposure time (Seconds) for (A-D) is 1/5. Concentrations for (A-B) is 5 µg/ml, (C) is 2 µg/ml and (D) is 0.5 µg/ml.
  • 3_MAb414_Pure_NPCP_Antibody_2_111417
    Western blot analysis of cell lysates from HaCaT, Daudi (Human), Raw264.7 (Mouse) and UMR106 (Rat) using Nuclear Pore Complex Proteins Mouse primary antibody and HRP Goat anti-Mouse secondary antibody (Cat. No. 405306). GAPDH (Cat. No. 919501) was used as a loading control.
  • 4_MAb414_PURE_NPC_Antibody_052022
    IHC staining using purified anti-NPC antibody (clone Mab414) on formalin-fixed paraffin-embedded human tonsil tissue. The tissue was incubated with 1 μg/mL of anti-NPC antibody overnight at 4°C, followed by incubation with 2.5 μg/mL of Alexa Fluor® 647 goat anti-mouse IgG antibody (red) (Cat. No. 405322) for one hour at room temperature. Nuclei were counterstained with DAPI (blue) (Cat. No. 422801), and the slide was mounted with ProLong™ Gold Antifade Mounting Solution. The image was captured with a 40x objective. Scalebar = 50 μM.
Compare all formats
Cat # Size Price Save
902907 25 µL ¥19,580
902901 100 µL ¥55,660
902902 500 µL ¥107,140
Description

Nuclear pores are large protein complexes that cross the nuclear envelope. The proteins that make up the nuclear pore complex are known as nucleoporins. About half of the nucleoporins typically contain solenoid protein domains—either an alpha solenoid or a beta-propeller fold, or in some cases both as separate structural domains. Each NPC contains at least 456 individual protein molecules and is composed of 30 distinct proteins (nucleoporins). The other half show structural characteristics typical of "natively unfolded" or intrinsically disordered proteins, i.e. they are highly flexible proteins that lack ordered secondary structure. These disordered proteins are the FG nucleoporins, so called because their amino-acid sequence contains many phenylalanine—glycine repeats.

Nuclear pore complexes allow the transport of molecules across the nuclear envelope. This transport includes RNA and ribosomal proteins moving from nucleus to the cytoplasm and proteins (such as DNA polymerase and lamins), carbohydrates, signaling molecules and lipids moving into the nucleus. Although smaller molecules simply diffuse through the pores, larger molecules may be recognized by specific signal sequences and then be diffused with the help of nucleoporins into or out of the nucleus.. Each of the eight protein subunits surrounding the actual pore (the outer ring) projects a spoke-shaped protein over the pore channel.

Nucleoporin p62 (p62) protein remains associated with the nuclear pore complex-lamina fraction. p62 is synthesized as a soluble cytoplasmic precursor of 61 kDa followed by modification that involve addition of N-acetylglucosamine residues, followed by association with other complex proteins.The protein encoded by this gene is a member of the FG-repeat containing nucleoporins and is localized to the nuclear pore central plug. This protein associates with the importin alpha/beta complex which is involved in the import of proteins containing nuclear localization signals. Multiple transcript variants of this gene encode a single protein isoform.

P62 is a serine/threonine rich protein of ~520 amino acids, with tetrapeptide repeats on the amino terminus and a series of alpha-helical regions with hydrophobic heptad repeats. P62 assembles into a complex containing 3 addition proteins, p60, p54 and p45 forming the p62 complex of ~235 kDa. Glycosylation appears to be involved in the assembly and disassembly of p62 into higher order complexes, and a serine/threonine rich linker region between Ser270 to Thr294 appear to be regulatory. The p62 complex is localized to both the nucleoplasmic and cytoplasmic sides of the pore complex and the relative diameter of p62 complex relative to the nuclear pore complex suggests it interacts in pore gating.

Antibodies to p62 complex are involved in 1 or more autoimmune diseases. P62 glycosylation is increased in diabetes. p62 is also more frequent in Stage IV primary biliary cirrhosis and is prognostic for severe disease. Reduced p62 production has been linked to Alzheimer's disease. It is thought oxidative damage of the p62 promoter is correlated with AD and other neurodegenerative disorders.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Human, Mouse, Rat
Reported Reactivity
Other species
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
The antibody was raised using a nuclear pore complex mixture.
Formulation
Phosphate-buffered solution + 0.03% Thimerosal.
Preparation
The antibody was purified by affinity chromatography.
Concentration
1 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C. Please note the storage condition for this antibody has been changed from -20°C to between 2°C and 8°C. You can also check your vial or your CoA to find the most accurate storage condition for this antibody.
Application

ICC - Quality tested
WB, IHC-P - Verified
IHC-F, IP, IEM - Reported in the literature, not verified in house

Recommended Usage

Each lot of this antibody is quality control tested by immunocytochemistry. For immunocytochemistry, a concentration range of 0.5 - 1 μg/mL (1:1000 - 1:2000 dilution) is recommended. For Western blotting, the suggested use of this reagent is 0.2 - 0.5 µg per mL (1:2000 - 1:5000). For immunohistochemical staining on formalin-fixed paraffin-embedded tissue sections, a concentration range of 0.5 - 1 µg/mL is suggested. For immunohistochemical staining on frozen tissue sections, a dilution of 1:500 is suggested. For immunoprecipitation and electron microscopy, the suggested dilution of this reagent is 1:5000. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

This antibody is effective in immunoblotting (WB), immunohistochemistry (IHC), immunofluorescence (IF), immunoprecipitation (IP) and immunoelectron microscopy (IEM). This antibody has been used successfully with frozen sections.

*Predicted MW = 62 kD

MAb414 is a reliable general purpose monoclonal antibody which recognizes a related family of NPC proteins. This antibody is ideal for studying the morphology and composition of the nucleus and nuclear envelope. It is also useful in studying changes in the nuclear structure during mitosis and meiosis.

Application References

(PubMed link indicates BioLegend citation)
  1. Zheng X, et al. 2012. J. Biol. Chem. 287:38254. (IF) PubMed
  2. Kimura T, et al. 2003. Mol Cell Biol. 23:1304. (IHC) PubMed
  3. Lopez-Soler RI, et al. 2001. J Cell Biol. 154:61. (IF, WB) PubMed
  4. Aris JP, Blobel G. 1989. J Cell Biol. 108:2059. (WB, IP, IF, EM) PubMed
  5. Davis LI, Blobel G. 1987. PNAS USA. 84:7552. (IP, IF) PubMed
  6. Edens LJ, Levy DL. 2014. J. Cell. Biol. 206:473.
  7. Davis LI, Blobel G. 1986. Cell. 45:699.
  8. Blobel G. 1985. PNAS USA 82:8527.
Product Citations
  1. Munafò M, et al. 2021. Elife. 10:. PubMed
  2. Yoo TY, et al. 2021. J Cell Biol. 220:. PubMed
  3. Mishra S, et al. 2022. J Cell Sci. 135: . PubMed
  4. Mauro MS, et al. 2022. Elife. 11: . PubMed
  5. Kono Y, et al. 2022. J Cell Biol. 221: . PubMed
  6. Richards L, et al. 2022. Cell Rep. 41:111590. PubMed
  7. Giacomini C, et al. 2016. Mol Biol Cell. 27: 35 - 47. PubMed
  8. Liu Z et al. 2019. Neuron. 102(3):587-601 . PubMed
  9. Ding B, et al. 2021. J Neurosci. 41:2024. PubMed
  10. Dewi FRP, et al. 2020. Autophagy. 1:. PubMed
  11. Rosso G, et al. 2019. Adv Sci (Weinh). 6:1801638. PubMed
  12. Mehta SJK, et al. 2021. Bio Protoc. 11:e3924. PubMed
  13. Liu Z, et al. 2022. J Clin Invest. . PubMed
  14. Magre I, et al. 2019. J Cell Sci. 132:jcs224501. PubMed
  15. Ben-Yishay R, et al. 2019. J Cell Biol. 218:2962. PubMed
  16. Fichtman B, et al. 2019. Nat Commun. 10:605. PubMed
  17. Zheng X, et al. 2012. J Biol Chem. 287:38254-38264. PubMed
  18. Mimura Y, et al. 2016. J Cell Sci. 129: 4200 - 4212. PubMed
  19. Alves N, et al. 2017. Sci Rep. 7:41519. PubMed
  20. Ahn JH, et al. 2019. Exp Mol Med. 51:64. PubMed
  21. Gleixner AM, et al. 2022. Nat Commun. 13:3380. PubMed
  22. Raghunayakula S, et al. 2015. PLoS One. 10: 0144508. PubMed
  23. Kuhn TM, et al. 2019. J Cell Biol. 218:2945. PubMed
  24. Berneking L, et al. 2016. PLoS Pathog. 12: 1005660. PubMed
  25. Ohkura M 2015. Genes Dev. 29: 1789-1794. PubMed
  26. Kamikawa Y, et al. 2021. Cell Death Discov. 7:152. PubMed
  27. Hamed M, et al. 2021. J Cell Sci. 134:. PubMed
  28. Chen AF, et al. 2022. Nat Methods. 19:547. PubMed
  29. Fichtman B, et al. 2019. Am J Hum Genet. 105:48:00. PubMed
  30. Golchoubian B, et al. 2022. J Cell Biol. 221:. PubMed
  31. Mukherjee RN, et al. 2020. Dev Cell. 395:54. PubMed
  32. Martino L et al. 2017. Developmental cell. 43(2):157-171 . PubMed
  33. Urbanek M, Michalak M, Krzyzosiak W 2017. Methods. 10.1016/j.ymeth.2017.04.002. PubMed
  34. Watters K, et al. 2017. J Virol. 91:. PubMed
  35. Cianciolo Cosentino C, et al. 2019. Sci Rep. 9:4750. PubMed
  36. Kittisopikul M, et al. 2021. J Cell Biol. 220:. PubMed
  37. He Y, et al. 2021. eLife. 10:00. PubMed
  38. Heijo H, et al. 2020. Mol Biol Cell. 31:2703. PubMed
  39. Bonnin E, et al. 2018. PLoS Genet. 14:e1007845. PubMed
  40. Wild P, et al. 2019. F1000Res. 8:198. PubMed
  41. Patil H, et al. 2019. Small GTPases. 10:146. PubMed
  42. Ogawa Y, et al. 2021. iScience. 24:103503. PubMed
  43. Wigington CP, et al. 2020. Molecular Cell. 79(2):342-358.e12. PubMed
  44. Dilsaver MR, et al. 2018. Mol Biol Cell. :mbcE18050277. PubMed
  45. Sołtysik K, et al. 2019. Nat Commun. 10:473. PubMed
  46. Behrens RT, et al. 2017. J Virol. 91. PubMed
  47. Chen P, et al. 2019. J Cell Biol. 218:4063. PubMed
  48. Niide T, et al. 2022. Front Cell Dev Biol. 10:857862. PubMed
  49. Duan T, et al. 2021. Current Biology. 31(7):1450-1462.e3. PubMed
RRID
AB_2565026 (BioLegend Cat. No. 902907)
AB_2565026 (BioLegend Cat. No. 902901)
AB_2565026 (BioLegend Cat. No. 902902)

Antigen Details

Biology Area
Cell Biology, Cell Motility/Cytoskeleton/Structure, Neuroscience, Neuroscience Cell Markers
Molecular Family
Nuclear Markers
Antigen References

1. Yoshimura S, et al. 2013. J. Cell Sci. 126:3141-50.

Gene ID
NA
UniProt
View information about Nuclear Pore Complex Proteins on UniProt.org

Other Formats

View All Nuclear Pore Complex Proteins Reagents Request Custom Conjugation
Description Clone Applications
Purified anti-Nuclear Pore Complex Proteins MAb414 ICC,WB,IHC-P,IHC-F,IP,IEM
Alexa Fluor® 594 anti-Nuclear Pore Complex Proteins MAb414 ICC
Direct-Blot™ HRP anti-Nuclear Pore Complex Proteins MAb414 WB
Alexa Fluor® 647 anti-Nuclear Pore Complex Proteins MAb414 ICC,ICFC
TotalSeq™-A0451 anti-Nuclear Pore Complex Proteins Hashtag 1 MAb414 PG
TotalSeq™-A0452 anti-Nuclear Pore Complex Proteins Hashtag 2 MAb414 PG
TotalSeq™-A0453 anti-Nuclear Pore Complex Proteins Hashtag 3 MAb414 PG
TotalSeq™-A0454 anti-Nuclear Pore Complex Proteins Hashtag 4 MAb414 PG
TotalSeq™-A0456 anti-Nuclear Pore Complex Proteins Hashtag 6 MAb414 PG
TotalSeq™-A0457 anti-Nuclear Pore Complex Proteins Hashtag 7 MAb414 PG
TotalSeq™-A0458 anti-Nuclear Pore Complex Proteins Hashtag 8 MAb414 PG
TotalSeq™-A0459 anti-Nuclear Pore Complex Proteins Hashtag 9 MAb414 PG
TotalSeq™-A0460 anti-Nuclear Pore Complex Proteins Hashtag 10 MAb414 PG
TotalSeq™-A0455 anti-Nuclear Pore Complex Proteins Hashtag 5 MAb414 PG
TotalSeq™-A0462 anti-Nuclear Pore Complex Proteins Hashtag 12 MAb414 PG
TotalSeq™-A0463 anti-Nuclear Pore Complex Proteins Hashtag 13 MAb414 PG
TotalSeq™-A0465 anti-Nuclear Pore Complex Proteins Hashtag 15 MAb414 PG
TotalSeq™-A0461 anti-Nuclear Pore Complex Proteins Hashtag 11 MAb414 PG
TotalSeq™-A0464 anti-Nuclear Pore Complex Proteins Hashtag 14 MAb414 PG
TotalSeq™-B0453 anti-Nuclear Pore Complex Proteins Hashtag 3 MAb414 PG
TotalSeq™-B0452 anti-Nuclear Pore Complex Proteins Hashtag 2 MAb414 PG
TotalSeq™-B0451 anti-Nuclear Pore Complex Proteins Hashtag 1 MAb414 PG
TotalSeq™-B0458 anti-Nuclear Pore Complex Proteins Hashtag 8 MAb414 PG
TotalSeq™-B0457 anti-Nuclear Pore Complex Proteins Hashtag 7 MAb414 PG
TotalSeq™-B0464 anti-Nuclear Pore Complex Proteins Hashtag 14 MAb414 PG
TotalSeq™-B0471 anti-Nuclear Pore Complex Proteins Hashtag 21 MAb414 PG
TotalSeq™-B0472 anti-Nuclear Pore Complex Proteins Hashtag 22 MAb414 PG
TotalSeq™-A0469 anti-Nuclear Pore Complex Proteins Hashtag 19 MAb414 PG
TotalSeq™-A0470 anti-Nuclear Pore Complex Proteins Hashtag 20 MAb414 PG
TotalSeq™-A0472 anti-Nuclear Pore Complex Proteins Hashtag 22 MAb414 PG
TotalSeq™-B0465 anti-Nuclear Pore Complex Proteins Hashtag 15 MAb414 PG
TotalSeq™-B0463 anti-Nuclear Pore Complex Proteins Hashtag 13 MAb414 PG
TotalSeq™-B0469 anti-Nuclear Pore Complex Proteins Hashtag 19 MAb414 PG
TotalSeq™-B0474 anti-Nuclear Pore Complex Proteins Hashtag 24 MAb414 PG
TotalSeq™-A0471 anti-Nuclear Pore Complex Proteins Hashtag 21 MAb414 PG
TotalSeq™-B0462 anti-Nuclear Pore Complex Proteins Hashtag 12 MAb414 PG
TotalSeq™-B0460 anti-Nuclear Pore Complex Proteins Hashtag 10 MAb414 PG
TotalSeq™-B0461 anti-Nuclear Pore Complex Proteins Hashtag 11 MAb414 PG
TotalSeq™-A0474 anti-Nuclear Pore Complex Proteins Hashtag 24 MAb414 PG
TotalSeq™-A0473 anti-Nuclear Pore Complex Proteins Hashtag 23 MAb414 PG
TotalSeq™-B0454 anti-Nuclear Pore Complex Proteins Hashtag 4 MAb414 PG
TotalSeq™-B0455 anti-Nuclear Pore Complex Proteins Hashtag 5 MAb414 PG
TotalSeq™-B0459 anti-Nuclear Pore Complex Proteins Hashtag 9 MAb414 PG
TotalSeq™-A0466 anti-Nuclear Pore Complex Proteins Hashtag 16 MAb414 PG
TotalSeq™-A0467 anti-Nuclear Pore Complex Proteins Hashtag 17 MAb414 PG
TotalSeq™-B0466 anti-Nuclear Pore Complex Proteins Hashtag 16 MAb414 PG
TotalSeq™-B0467 anti-Nuclear Pore Complex Proteins Hashtag 17 MAb414 PG
TotalSeq™-B0470 anti-Nuclear Pore Complex Proteins Hashtag 20 MAb414 PG
TotalSeq™-B0468 anti-Nuclear Pore Complex Proteins Hashtag 18 MAb414 PG
TotalSeq™-A0468 anti-Nuclear Pore Complex Proteins Hashtag 18 MAb414 PG
TotalSeq™-B0456 anti-Nuclear Pore Complex Proteins Hashtag 6 MAb414 PG
TotalSeq™-B0473 anti-Nuclear Pore Complex Proteins Hashtag 23 MAb414 PG
Go To Top Version: 8    Revision Date: 09/21/2023

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • Purified anti-Nuclear Pore Complex Proteins

    1_MAb414_Pure_NPCP_Antibody_111417
    Immunofluorescence of HeLa with Nuclear Pore Complex Protein...
    3_MAb414_Pure_NPCP_Antibody_2_111417
    Western blot analysis of cell lysates from HaCaT, Daudi (Hum...
    2_MAb414_Pure_NPCP_Antibody_ICC_122117
    HeLa cells were fixed with 4% paraformaldehyde (PFA) for 15 ...
    4_MAb414_PURE_NPC_Antibody_052022
    IHC staining using purified anti-NPC antibody (clone Mab414)...

  • Alexa Fluor® 594 anti-Nuclear Pore Complex Proteins

    MAb414_AF594_NPCP_ICC_Antibody_050319
    HeLa cells were fixed with 100% methanol for 15 minutes at -...

  • Direct-Blot™ HRP anti-Nuclear Pore Complex Proteins

    MAb414_DBHRP_Nuclear_Pore_Complex_Proteins_Antibody_071116
    15 µg of total protein extract from HeLa was resolved by ele...

  • Alexa Fluor® 647 anti-Nuclear Pore Complex Proteins

    Mab414_A647_Nuclear_Pore_Complex_Antibody_012618
    HeLa cells were fixed with methanol for 10 minutes and block...
    Mab414_A647_Nuclear_Pore_Complex_Antibody_112618
    HeLa cells were fixed with 4% paraformaldehyde (PFA) for 15 ...
    Mab414_A647_Nuclear_Pore_Complex_Antibody_2_012618
    HeLa cells were fixed with 4% paraformaldehyde (PFA) for 15 ...
    Mab414_A647_Nuclear_Pore_Complex_Antibody_3_081219
    Jurkat cells were fixed, permeabilized and intracellularly s...

  • TotalSeq™-A0451 anti-Nuclear Pore Complex Proteins Hashtag 1

  • TotalSeq™-A0452 anti-Nuclear Pore Complex Proteins Hashtag 2

  • TotalSeq™-A0453 anti-Nuclear Pore Complex Proteins Hashtag 3

  • TotalSeq™-A0454 anti-Nuclear Pore Complex Proteins Hashtag 4

  • TotalSeq™-A0456 anti-Nuclear Pore Complex Proteins Hashtag 6

  • TotalSeq™-A0457 anti-Nuclear Pore Complex Proteins Hashtag 7

  • TotalSeq™-A0458 anti-Nuclear Pore Complex Proteins Hashtag 8

  • TotalSeq™-A0459 anti-Nuclear Pore Complex Proteins Hashtag 9

  • TotalSeq™-A0460 anti-Nuclear Pore Complex Proteins Hashtag 10

  • TotalSeq™-A0455 anti-Nuclear Pore Complex Proteins Hashtag 5

  • TotalSeq™-A0462 anti-Nuclear Pore Complex Proteins Hashtag 12

  • TotalSeq™-A0463 anti-Nuclear Pore Complex Proteins Hashtag 13

  • TotalSeq™-A0465 anti-Nuclear Pore Complex Proteins Hashtag 15

  • TotalSeq™-A0461 anti-Nuclear Pore Complex Proteins Hashtag 11

  • TotalSeq™-A0464 anti-Nuclear Pore Complex Proteins Hashtag 14

  • TotalSeq™-B0453 anti-Nuclear Pore Complex Proteins Hashtag 3

  • TotalSeq™-B0452 anti-Nuclear Pore Complex Proteins Hashtag 2

  • TotalSeq™-B0451 anti-Nuclear Pore Complex Proteins Hashtag 1

  • TotalSeq™-B0458 anti-Nuclear Pore Complex Proteins Hashtag 8

  • TotalSeq™-B0457 anti-Nuclear Pore Complex Proteins Hashtag 7

  • TotalSeq™-B0464 anti-Nuclear Pore Complex Proteins Hashtag 14

  • TotalSeq™-B0471 anti-Nuclear Pore Complex Proteins Hashtag 21

  • TotalSeq™-B0472 anti-Nuclear Pore Complex Proteins Hashtag 22

  • TotalSeq™-A0469 anti-Nuclear Pore Complex Proteins Hashtag 19

  • TotalSeq™-A0470 anti-Nuclear Pore Complex Proteins Hashtag 20

  • TotalSeq™-A0472 anti-Nuclear Pore Complex Proteins Hashtag 22

  • TotalSeq™-B0465 anti-Nuclear Pore Complex Proteins Hashtag 15

  • TotalSeq™-B0463 anti-Nuclear Pore Complex Proteins Hashtag 13

  • TotalSeq™-B0469 anti-Nuclear Pore Complex Proteins Hashtag 19

  • TotalSeq™-B0474 anti-Nuclear Pore Complex Proteins Hashtag 24

  • TotalSeq™-A0471 anti-Nuclear Pore Complex Proteins Hashtag 21

  • TotalSeq™-B0462 anti-Nuclear Pore Complex Proteins Hashtag 12

  • TotalSeq™-B0460 anti-Nuclear Pore Complex Proteins Hashtag 10

  • TotalSeq™-B0461 anti-Nuclear Pore Complex Proteins Hashtag 11

  • TotalSeq™-A0474 anti-Nuclear Pore Complex Proteins Hashtag 24

  • TotalSeq™-A0473 anti-Nuclear Pore Complex Proteins Hashtag 23

  • TotalSeq™-B0454 anti-Nuclear Pore Complex Proteins Hashtag 4

  • TotalSeq™-B0455 anti-Nuclear Pore Complex Proteins Hashtag 5

  • TotalSeq™-B0459 anti-Nuclear Pore Complex Proteins Hashtag 9

  • TotalSeq™-A0466 anti-Nuclear Pore Complex Proteins Hashtag 16

  • TotalSeq™-A0467 anti-Nuclear Pore Complex Proteins Hashtag 17

  • TotalSeq™-B0466 anti-Nuclear Pore Complex Proteins Hashtag 16

  • TotalSeq™-B0467 anti-Nuclear Pore Complex Proteins Hashtag 17

  • TotalSeq™-B0470 anti-Nuclear Pore Complex Proteins Hashtag 20

  • TotalSeq™-B0468 anti-Nuclear Pore Complex Proteins Hashtag 18

  • TotalSeq™-A0468 anti-Nuclear Pore Complex Proteins Hashtag 18

  • TotalSeq™-B0456 anti-Nuclear Pore Complex Proteins Hashtag 6

  • TotalSeq™-B0473 anti-Nuclear Pore Complex Proteins Hashtag 23

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account